Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
immunotherapy
immunotherapy
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By
Trading Desk
June 15, 2021
Tech
New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells
By
Research Team
March 16, 2021
Health
As mutant COVID variants multiply, the hunt is on for a ‘universal’ kill-all vaccine
By
News Correspondent
February 19, 2021
Magazine
‘Miracle’ cancer treatments could be a blessing for investors too
By
Trading Desk
February 13, 2020
Microsoft Co-Founder Paul Allen Says His Cancer Has Returned, Expresses Optimism
By
Senior Editor
October 1, 2018
Health
The Secret to Cancer Treatment May Be In Our Guts
By
Contributing Writer
November 3, 2017
Health
Here’s Why Shares in This Former Pfizer Target Are Tanking
By
Staff Writer
July 27, 2017
Health
Sean Parker: This Is How Tech Billionaires Do Philanthropy
By
Senior Editor
November 3, 2016
Health
First CRISPR Clinical Trial in Humans Is Approved by Federal Regulators
By
Staff Writer
June 22, 2016
Health
Sean Parker Is Funding the First Human Trials of a Revolutionary Cancer Treatment
By
Market Analyst
June 21, 2016
Health
This Key Merck Cancer Drug Just Got a Huge Boost
By
Editorial Team
June 16, 2016
Health
These Are the Most Promising Experimental Cancer Drugs
By
News Correspondent
June 9, 2016
Health
This Obscure Biotech Company May Have a Game-Changing Cancer Med On Its Hands
By
Financial Writer
June 6, 2016
Health
Here’s Why Worldwide Cancer Drug Spending Spiked Last Year
By
Contributing Writer
June 2, 2016
Health
Michael Bloomberg, Others Kick in $125 Million for New Cancer Center
By
Financial Writer
March 29, 2016
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Senior Editor
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Staff Writer
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
News Correspondent